Mergermarket: Limbix Eyeing Series B Next Year to Commercialize Digital Therapeutic for Depression, CEO Says

May 13, 2020

O’Melveny represented Limbix in its US$9 million Series A funding round, this article reported. Limbix is a digital therapeutic company for behavioral health and aims to complete a Series B funding round in the first half of 2021, Mergermarket reported. The capital will support commercialization of its product.